Dasatinib, also known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel. Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinases inhibitor approved for use in patients with chronic myelogenou
Molecular Weight:
488.01
Purity:
99% (HPLC)
Form:
Off-white to pale yellow powder
CAS Number:
[302962-49-8]
* VAT and and shipping costs not included. Errors and price changes excepted